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Abstract: 
The aim of this work was to develop validate a dissolution test for Methyldopa and Hydrochlorothiazide in 
combination tablets using spectrophotometric method. The dissolution established conditions were 900 mL of 
0.1M HCl pH 1.0 as dissolution medium, using a paddle apparatus at a stirring rate of 50 rpm. The drug 
release was evaluated by UV spectrophotometric method the areas of solution were recorded at 274-284 nm 
and266-276 nm for Methyldopa and Hydrochlorothiazide respectively. It can be concluded that the method 
developed consists in an efficient alternative for assay of dissolution for tablets. The method was validated to 
meet requirements for a global regulatory filing which includes linearity, precision, accuracy robustness and 
ruggedness. In addition, filter suitability and drug stability in medium were demonstrated 
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INTRODUCTION:  
Methyldopa (MD) (Fig. 1) is 3-(3, 
4dihydrophenyl)-2-Methyl-L-alanine sequihydrate 
is Chemical name of methyldopa [1].  It is White to 
yellowish white, Fine powder which may contain 
friable lumps it is slightly soluble in water, very 
slightly soluble in Ethanol (95%), practically 
insoluble in chloroform and in ether. It is freely 
soluble in dilute hydrochloric acid [2].  
 Hydrochlorothiazide (HCTZ) (Fig .2) is 6-chloro-
3, 4dihydro-2H-1, 2, 4, benzathiadiazine-7-
suiphonamide [3].  It is White or almost white, 
crystalline powder, odorless. Soluble in acetone, 
sparingly soluble in ethanol (95%).Very slightly 
soluble in water, it dissolves in dilute solution of 
alkali hydroxides [4]. Literature survey revealed 
UV-Visible spectrophotometric methods such as 
simultaneous equation method, Dual Wavelength 
method [5,6]
 
and RP-HPLC [7,8] for the estimation 
of MD and HCTZ  alone or in combination with 
other drugs. No method has been reported for this 
combination by using this mobile phase. The 
present work therefore emphasizes on the 
quantitative estimation of MD and HCTZ in bulk 
and pharmaceutical formulation by HPLC. The 
proposed method was validated as per the 
International Conference on Harmonization (ICH) 
analytical method validation guidelines [9,10]. 
 
 
Fig. 1: Chemical Structure of Methyldopa 
 
Fig. 2: Chemical Structure of 
Hydrochlorothiazide 
                
MATERIAL AND METHODS: 
Instrumentation 
Dissolution test was performed in a 
ELECTROLAB (VK7025)   Model (TDT-06L) 
[11] dissolution apparatus, multi-bath (n=6), in 
accordance to USP Pharmacopoeia general 
method. The medium were vacuum degassed under 
in house vacuum and weremaintained at 37.0 ± 
0.5°C by using a thermostatic bath. A double-beam 
UV-Visiblespectrophotometer (Model: UV 
1800,Shimadzu] with a fixed slit width (2 nm)using 
1.0 cm quartz cell was used for all absorbance 
measurements. Elico pH analyzer 
(Model: Elico 11610) was used to determine the 
pH of all solutions. 
 
Chemicals 
Pharmaceutically pure sample of Methyldopa and 
Hydrochlorothiazide obtain form Flamigo Private 
Ltd.Nanded & Ajanta pharma. Chitegaon. 
Formulations of Methyldopa and 
Hydrochlorothiazide Aldoril tablet(250mg of 
MD+25mg of HCTZ) purchased from local market.  
 
Method for stability indicating dissolution 
media selection and for dissolution study 
 Stability studies 
In stability study nine dissolution media were 
selected and prepared such as distilled water, 0.1M 
HCl, Acetate buffer 5.5,  and 6.8 phosphate buffers 
as per USP guidelines [United States 
Pharmacopoeia XXX, 2007]. Stock solutions of 
MD and HCTZ were prepared by dissolving 
accurately weighed 10 mg of both drug in 100 ml 
of distilled water, 0.1M HCl, Acetate buffe 5.5, and 
6.8 phosphate buffers separately to obtain 100 
μg/ml solutions. All the solutions were sonicated 
using ultrasonicater to dissolve the drug. From 
these solutions 1 ml was pipette out into 10 ml 
volumetric flask and diluted with the same solvent 
system up to the mark to obtain 10 μg/ml solutions. 
Two sets of 10 μg/ml solutions of MD and HCTZ 
are prepared and stability was tested in the above 
prepared dissolution media at room temperature 
(RT) and 37oC in an incubator (Thermo lab) for 48 
hrs separately. These samples are studied at 0, 24 
and 48 hrs interval by using a double-beam UV-
visible spectrophotometer (shimadzu UV1800) 
connected to UV probe software. The λmax and 
absorbance value was measured for all the 
solutions and deviations in the values are recorded 
which indicates stability in 0.1M HCL. These 
stable dissolution Medias are used for further 
dissolution studies of both the drugs.  
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Table No 1: Media Selection of MD 
 
Medium 0 HOUR 24 HOUR 48 HOUR %  CV 
λmax Absorbance λmax Absorbance λmax Absorbance 
Distilled 
water 
279.40 0.145 279.40 0.140 279.40 0.137 2.87307 
0.1M 
HCL 
279.60 0.150 279.60 0.155 279.85 0.158 4.760393 
Buffer 
(6.8) 
280 0.121 280 0.126 280 0.144 9.281 
Acetate 
Buffer 
(5.5) 
279.90 0.131 280 0.135 280 0.145 5.263 
 
Table No 2: Media Selection of HCTZ 
 
Medium 0 HOUR 24 HOUR 48 HOUR %  CV 
λmax Absorbance λmax Absorbance λmax Absorbance 
Distilled 
water 
271.40 0.698 271.20 0.742 271.30 0.791 6.2553 
0.1M 
HCL 
271.40 0.580 271.20 0.583 271.20 0.585 5.9222 
Buffer 
(6.8) 
271.40 0.687 271 0.700 271 0.676 1.74705 
Acetate 
Buffer 
(5.5) 
271.20 0.523 271 0.566 271 0.591 6.15192 
 
Simultaneous Spectrophotometric 
Determination of Methydopa and 
Hydrochlorothiazide by Area under Curve 
Method 
The release of kinetic of Methyldopa and 
Hydrochlorothiazide from tablets was studied by  
conducting dissolution tests. Dissolution tests 
performed using USP type 2 dissolution apparatus 
and 900ml of 0.1N Hcl at 37± 0.50c at 50rpm 10ml 
sample were withdrawn at the intervals of 
5,10,,15,20,25,30,35,40,45,60min. Sampling was 
carried out and every time replaced with fresh 10ml 
with 0.1N Hcl. The areas of solution were recorded 
at 274-284 nm and266-276 nm for MD and HCTZ 
respectively using 0.1N Hcl as blank. The 
dissolution studies were performed in triplicate 
(n=3). 
 
 
 
Fig 3: Overlain Spectra of MD and HCTZ 
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Table 3: Calculation by AUC Method 
 
Sr. 
No 
Sampling Time       Area at Percentage Released (%) 
274-284 266-276 
1  MD HCTZ MD HCTZ 
2 5 0.128 0.089 48.4 47.21 
3 10 0.148 0.108 54.63 56.58 
4 15 0.175 0.138 61.82 64.99 
5 20 0.224 0.164 68.85 71.65 
6 25 0.235 0.177 79.8 77.41 
7 30 0.241 0.189 85.59 83.58 
8 35 0.252 0.211 90.47 92.7 
9 40 0.259 0.221 99.90 99.79 
10 45 0.63 0.225 100.2 100.4 
11 60 0.255 0.218 95.48 96.59 
 
 
Fig.4: AUC Graph 
Method Validation 
Linearity  
The linearity of Methyldopa response was 
evaluated from the range of 10-60µg/ml. And that 
for Hydrochlorothiazide was 2-14µg/ml and 
showed a good correlation coefficient. To assess 
linearity, the standard curves Methyldopa and 
Hydrochlorothiazide are constructed by plotting 
concentration (µg/ml) verses absorbance . 
Precision 
The precision of the method is evaluated by 
measuring the repeatability in two different UV Vis 
spectrophotometers 
Recovery 
The accuracy is evaluated by applying proposed 
method to the analysis of mixture of the tablet and 
with known amount of the Methyldopa and 
Hydrochlorothiazide working standard. 
Corresponding to the concentration of 80, 100,and 
120% which were subjected to dissolution test 
conditions described above 
Ruggedness 
Ruggedness of the method is determined by 
carrying out the analysis by two different analysis 
and the respective dissolution values are calculated 
Stability indicating assay method 
Preparation of stock solution 
Standard stock solution of Methyldopa & 
Hydrochlorothiazide was prepared by dissolving 
10mg of Methyldopa & Hydrochlorothiazide in 
100ml of 0.1N Hcl which gives 100µg/ml solution. 
Preparation of working solution 
From the above stock solution 1ml was transferred 
into 10ml volumetric flask &The volume made was 
up to mark with 0.1N Hcl to give 10µg/ml. 
 
Preparation of Blank solution 
\In separate 10ml volumetric flask, each containing 
5ml of solvents used for dedradation such as 0.1N 
Hcl, 1N Hcl, 0.1N NaoH, 1N NaoH& 3% 
H2O2&Neutrlise with solvent & Volume was made 
up with 0.1N Hcl. 
Acid degradation 
10 ml volume flask containing 3 ml stock solution  
of  Methyldopa & Hydrochlorothiazide 5 ml (0.1 & 
1 N Hcl) , was added & heated at 600c for 3 
hours.Which was then neutralized with proper 
solvent and final volume made up to mark with 
NaoH to form solution 10µg/ml of drug stock 
solution. 
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Fig 5: Acid degradation of MD 10µg/ml 
 
Fig 6: Acid degradation HCTZ 10µg/ml 
 
Alkali degradation 
10 ml volumetric flack containing 3 ml stock 
solution of  Methyldopa & Hydrochlorothiazide,  5 
ml (0.1 & 1N NaOH) was added & heated at 600c 
for 3 hours.Which was then neutralized with proper 
solvent and final volume made up to mark with 0.1 
N Hcl to form solution 10µg/ml of drug stock 
solution. 
 
Fig 7: Alkali degradation of MD 10µg/ml 
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Fig 8: Alkali degradation of HCTZ10µg/ml 
 
Oxidation degradation 
10 ml volumetric flack containing,3 ml  stock 
solution of  Methyldopa & Hydrochlorothiazide, 5 
ml 3% H2O2 was added & Kept in 3hr for room 
temperature and  final volume made up to mark 
with NaOH to form solution 10µg/ml of drug stock 
solution. 
      Fig 9 : Oxidationdegradation MD 10µg/ml 
 Fig 10: Oxidative degradation HCTZ 10µg/ml 
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Thermal degradation 
50mg of MD & HCTZ  was weighted & kept in the oven & temperature was maintained at 800c for 3hrs from 
this 1 mg of exposed MD & HCTZ was transferred in 100ml volumetric flack and final volume made upto 0.1N 
Hcl. 
                       Fig 11: Thermal degradation MD10µg/ml 
                   Fig 12: Thermal degradation HCTZ 10µg/ml 
Photolytic Degradation 
50mg of MD & HCTZ was exposed in sunlight & degradation drug not achieved. From this 1mg exposed MD 
& HCTZ was transfereed in 100ml volumetric flack and final volume made with 0.1N Hcl. 
 
Fig 13: Photolytic degradation MD10µg/ml 
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Fig14: Photolytic degradation HCTZ10µg/ml 
 
 
Table 4: Repeatability and intermediate precision of the dissolution method 
   Method   Mean  Standard 
deviation 
Coefficient of 
variation 
Standard error 
 Intraday 
AUC MD HCTZ MD HCTZ MD HCTZ MD HCTZ 
 99.94 99.94 0.036 0.035 0.036 0.0351 0.0208 0.0202 
 Interday 
 99.93 99.96 0.0404 0.0152 0.0404 0.015 0.0233 0.0088 
  
Method               Analyst1               Analyst2 
MD HCTZ MD HCTZ 
AUC 99.81 99.84 99.70 99.78 
     
Mean 99.72 99.78 99.79 99.85 
n=3 n=3, SD= standard deviation %RSD=  Relative standard deviation SE= Standard error 
 
 
CONCLUSION: 
The Area under curve Method requires only 
measurement of area at selected wavelength. Area 
under curve, have been developed for 
determination of MD & HCTZ in tablet dosage 
form. From the statistical result, it can be 
concluded that this method was accurate, precise, 
robust and reproducible. A simple dissolution test 
developed and validated for Methyldopa and 
Hydrochlorothiazide tablets are considered 
satisfactory. The conditions that allowed the 
dissolution determination ware 900 mL of 0.1 M 
HCl at 37.0 ± 0.5 ºC, paddle apparatus, 50 rpm 
stirring speed and filtration with 0.45 μ cellulose 
acetate membrane filters. In these conditions, 
Methyldopa and Hydrochlorothiazide stability is 
good. The percent drug delivery is higher than 90% 
in 40 minutes for both drugs in evaluated products. 
Therefore, the proposed method was successfully 
applied and suggested for the quality control 
 Level of 
% 
Recovery 
Amt. Present 
(mcg/tab) 
Amt.of standard 
added(mcg/ta) 
Total Amt. 
Recoverd 
(mcg) 
% Recovery 
MD HCTZ MD HCTZ MD HCTZ MD HCTZ 
AUC 80 27 2.7 21.6 2.16 48.6 4.86 99.78 99.16 
100 27 2.7 27 2.7 54 5.4 99.59 100.1
3 
120 27 2.7 32.4 3.24 59.4 5.94 99.83 99.81 
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studies of Methyldopa and Hydrochlorothiazide 
pharmaceutical dosage forms contributing to assure 
the therapeutic efficacy of the drug. 
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